Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GROPPE C")

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

INFLUENCE OF ESTROGEN RECEPTOR STATUS ON RESPONSE TO COMBINATION CHEMOTHERAPY FOR RECURRENT BREAST CANCERMORTIMER J; REIMER R; GREENSTREET R et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 9-10; PP. 763-766; BIBL. 17 REF.Article

THERAPY FOR ADVANCED COLORECTAL CANCER WITH A COMBINATION OF 5-FU AND ANGUIDINE: A SOUTHWEST ONCOLOGY GROUP STUDYGOODWIN W; STEPHENS R; MCCRACKEN JD et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 359; BIBL. 3 REF.Article

CHEMOTHERAPY OF ACUTE LEUKEMIA. A COMPARISON OF VINCRISTINE, CYTARABINE, AND PREDNISONE ALONE AND IN COMBINATION WITH CYCLOPHOSPHAMIDE OR DAUMORUBICINCOLTMAN CA JR; BODEY GP; HEWLETT JS et al.1978; ARCH. INTERN. MED.; USA; DA. 1978; VOL. 138; NO 9; PP. 1342-1348; BIBL. 10 REF.Article

PHASE II EVALUATION OF FTORAFUR IN PREVIOUSLY UNTREATED COLORECTAL CANCER. A SOUTHWEST ONCOLOGY GROUP STUDYBUROKER T; PADILLA F; GROPPE C et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 1; PP. 48-51; BIBL. 18 REF.Article

COMBINATION CHEMOTHERAPY PLUS BCG IN THE TREATMENT OF DISSEMINATED MALIGNANT MELANOMA: A SOUTHWEST ONCOLOGY GROUP STUDYCOSTANZI JJ; MUHYI AL SARRAF; GROPPE C et al.1982; MED. PEDIATR. ONCOL.; ISSN 0098-1532; USA; DA. 1982; VOL. 10; NO 3; PP. 251-258; BIBL. 11 REF.Article

5FU INFUSION WITH MITOMYCIN-C VS. 5FU INFUSION WITH METHYL-CCNU IN THE TREATMENT OF ADVANCED UPPER GASTROINTESTINAL CANCERBUROKER T; KIM PN; GROPPE C et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 4; PP. 1215-1221; BIBL. 8 REF.Article

5FU INFUSION WITH MITOMYCIN-C VERSUS 5FU INFUSION WITH METHYL-CCNU IN THE TREATMENT OF ADVANCED COLON CANCER: A SOUTHWEST ONCOLOGY GROUP STUDYBUROKER T; KIM PN; GROPPE C et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 3; PP. 1228-1233; BIBL. 10 REF.Article

Combination chemotherapy of metastatic thyroid cancer = Chimiothérapie combinée du cancer métastatique de la thyroïde. Un essai phase IIBUKOWSKI, R. M; BROWN, L; WEICK, J. K et al.American journal of clinical oncology. 1983, Vol 6, Num 5, pp 579-581, issn 0277-3732Article

Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinomaSMITH, G. W; BUKOWSKI, R. M; HEWLETT, J. S et al.Cancer. 1984, Vol 54, Num 8, pp 1513-1516, issn 0008-543XArticle

Aggressive doxorubicin-containing regimen (prednisome, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer = Traitement agressif par association de (prednisone, méthotrexate, 5FU, adriamycine et cyclophosphamide; PM-FAC) dans les tumeurs du sein métastatiques, récepteur des œstrogènes-négativesMORTIMER, J; LIVINGSTON, R. B; HARDESTY, I. J et al.Cancer treatment reports. 1984, Vol 68, Num 7-8, pp 1017-1018, issn 0361-5960Article

Tamoxifen therapy and colectoral adenocarcinoma: a southwest oncology group studyPANNETIERE, F. J; GROPPE, C. W; ATHENS, J. W et al.Cancer treatment reports. 1985, Vol 69, Num 1, pp 113-114, issn 0361-5960Article

Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a southwest oncology group studyTRANUM, B. L; DIXON, D; GROPPE, C et al.Cancer treatment reports. 1987, Vol 71, Num 6, pp 643-644, issn 0361-5960Article

  • Page / 1